These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-005544-79 Adalimumab (Humira) as add-on therapy in the treatment of patients with severe persistent therapy resistant asthma not-yet-due
Completed, but no date Terminated 2006-000487-92 A Phase II, Randomised, Double Blind, Placebo Controlled Study examining the suitability of Phenytoin Sodium Topical Gel in the treatement of Venous Ulcers bad-data
Ongoing 2008-005657-38 Transversus Abdominis Plane Block for Analgesia in Renal Transplantation: A Randomised Controlled Trial not-yet-due
Ongoing 2014-002988-16 The Use of Milrinone in Neonates with Persistent Pulmonary Hypertension of the Newborn: A Randomised Controlled Trial Pilot Study (MINT 1) not-yet-due
Not reported 2015-000499-89 To measure the effects of Aspirin loading dose of 300mgs in healthy controls using AA LTA and the Dynamic Platelet Function Assay (DPFA). 2017-06-20 due-trials
No trial status on register 2015-004526-33 A Randomised Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score bad-data
Ongoing 2015-005421-40 The use of topical Glyceryl Trinitrate (GTN) and eccentric exercises in the treatment of mid portion Achilles Tendinopathy: a randomised placebo controlled trial not-yet-due
Ongoing 2016-001906-41 A randomised control trial of intra articular injectates in knee osteoarthritis: A comparison of corticosteroid (Methylprednisolone Acetate) and NSAID (Ketorolac tromethamine) injections not-yet-due
Not reported 2016-003181-12 Can sonographic assessment of pulmonary vascular reactivity following maternal hyperoxygenation therapy predict neonatal outcome in fetuses at risk of pulmonary hypertension? 2018-07-22 due-trials